Hongli Sun
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 3
- Molecular Biology top 10%
- RNA modifications and cancer 5
- Ion channel regulation and function 5
- Circular RNAs in diseases 3
- Physiology top 10%
-
- Neuroscience and Neuropharmacology Research 3
-
- Ferroptosis and cancer prognosis 3
-
- Autophagy in Disease and Therapy 3
- Journals
- Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hongli Sun
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 304
- Molecular Biology 707
- Cardiology and Cardiovascular Medicine 200
- Physiology 31
- Cellular and Molecular Neuroscience 98
Countries citing papers authored by Hongli Sun
This map shows the geographic impact of Hongli Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongli Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongli Sun more than expected).
Fields of papers citing papers by Hongli Sun
This network shows the impact of papers produced by Hongli Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongli Sun. The network helps show where Hongli Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongli Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 26 | |
| 5 | 2022 | 56 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 42 | |
| 8 | 2021 | 7 | |
| 9 | 2021 | 78 | |
| 10 | 2020 | 29 | |
| 11 | 2019 | 44 | |
| 12 | 2018 | 145 | |
| 13 | 2017 | 29 | |
| 14 | 2016 | 31 | |
| 15 | 2015 | 58 | |
| 16 | 2013 | 16 | |
| 17 | 2013 | 32 | |
| 18 | 2006 | 32 | |
| 19 | 2006 | 18 | |
| 20 | 2005 | 17 |
About Hongli Sun
Hongli Sun is a scholar working on Cancer Research, Physiology and Biophysics, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (5 papers), Ion channel regulation and function (5 papers), MicroRNA in disease regulation (3 papers), Ferroptosis and cancer prognosis (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Autophagy in Disease and Therapy (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (304 citations), Molecular Biology (707 citations) and Cardiology and Cardiovascular Medicine (200 citations). Hongli Sun has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yonggang Cao, Hanping Qi, Xiu‐Ling Deng, Pilong Shi, Lina Ba, Chao Song, Yunping Chen, Hao Pan, Baofeng Yang and Jingquan Gao. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.